PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Smaller Companies Trust PLC Regulatory News (BRSC)

Share Price Information for BlackRock Smaller Companies Trust PLC (BRSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,480.00
Bid: 1,480.00
Ask: 1,484.00
Change: -4.00 (-0.27%)
Spread: 4.00 (0.27%)
Open: 1,500.00
High: 1,500.00
Low: 1,480.00
Prev. Close: 1,484.00
BRSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

23 Dec 2020 17:20

BlackRock Smaller Companies Trust Plc - Portfolio Update

BlackRock Smaller Companies Trust Plc - Portfolio Update

PR Newswire

London, December 23

The information contained in this release was correct as at 30 November 2020. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

BLACKROCK SMALLER COMPANIES TRUST PLC (LEI:549300MS535KC2WH4082) 

All information is at 30 November 2020 and unaudited.Performance at month end is calculated on a capital only basis 

One month %Three months %One year %Three years %Five years %
Net asset value*11.39.51.38.351.0
Share price*13.120.7-5.415.854.3
Numis ex Inv Companies + AIM Index11.010.52.2-4.520.6

*performance calculations based on a capital only NAV with debt at par, without income reinvested. Share price performance calculations exclude income reinvestment.Sources: BlackRock and Datastream

At month end

Net asset value Capital only (debt at par value):1,568.18p
Net asset value Capital only (debt at fair value):1,550.57p
Net asset value incl. Income (debt at par value)1:1,569.53p
Net asset value incl. Income (debt at fair value)1:1,551.92p
Share price:1,484.00p
Discount to Cum Income NAV (debt at par value):5.5%
Discount to Cum Income NAV (debt at fair value):4.4%
Net yield2:2.2%
Gross assets3:£836.0m
Gearing range as a % of net assets:0-15%
Net gearing including income (debt at par):5.4%
Ongoing charges ratio (actual)4:0.7%
Ordinary shares in issue5:48,829,792

Includes net revenue of 1.35p

Yield calculations are based on dividends announced in the last 12 months as at the date of release of this announcement, and comprise the second interim dividend of 19.7 pence per share (announced on 3 June 2020, ex-dividend on 11 June 2020) and the first interim dividend of 12.8 pence per share (announced on 5 November 2020, ex-dividend on 12 November 2020, pay date 2 December 2020).

Includes current year revenue.

As reported in the Annual Financial Report for the year ended 29 February 2020 the Ongoing Charges Ratio (OCR) was 0.7%. The OCR is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation.

Excludes 1,163,731 ordinary shares held in treasury.

Sector Weightings% of portfolio
Industrials26.9
Financials18.9
Consumer Services15.6
Consumer Goods12.8
Technology10.9
Health Care5.9
Basic Materials5.6
Telecommunications1.2
Oil & Gas1.1
Materials1.1
-----
Total100.0
=====

Country Weightings% of portfolio
United Kingdom97.7
United States1.2
Singapore0.5
France0.3
Guernsey0.3
-----
Total100.0
=====

Ten Largest Equity Investments Company% of portfolio
Watches of Switzerland2.3
YouGov2.2
Grafton Group1.9
IG Design Group1.9
Pets at Home1.9
Team 171.8
CVS Group1.8
Breedon1.8
Ergomed1.8
Impax Asset Management1.7

Commenting on the markets, Roland Arnold, representing the Investment Manager noted:During November the Company’s NAV per share rose by 11.3%1 to 1,568.18p, outperforming our benchmark index which returned 11.0%1; for comparison the FTSE 100 Index rose by 12.4%1 (all calculations on a capital only basis).

Equity markets rallied during November as positive COVID-19 vaccine results showing better than expected efficacy from three candidates (Pfizer/BioNTech, Moderna and Oxford/AstraZeneca), sparked one of the sharpest rotations away from growth and into value shares on record. The rotation saw many of the biggest losers this year making the greatest gains during November, resulting in UK and European indices outperforming other developed equity markets. After several uncertain days, markets also received a boost from the outcome of the US election, which saw Joe Biden’s Democrats win the White House but the Republicans hold the senate, arguably the most market friendly result.

Equity market moves during November were heavily driven by the rotation from growth stocks into more value orientated areas of the market, a rotation which also drove much of the Company’s NAV performance for the month. However, despite this headwind to our growth bias style, actions taken earlier in the year to diversify the portfolio, and some positive updates from companies that continue to successfully navigate this challenging year, resulted in outperformance. IG Design Group reported sales ahead of expectations as people have not held back on Christmas preparations (decorations, gift packaging and crackers), despite the unprecedented challenges of 2020. Meanwhile the company has seen strong demand for its craft kits as families have embraced many ‘at home activities’ during the year. Our holding in Central Asia metals rallied with the mining sector and strengthening copper price. The shares also benefited from the announcement that the company would resume payment of its interim dividend, which was deferred earlier this year). Shares in Pebble Group rose in response to a positive trading update, which confirmed that the group is on track to meet full year expectations for the year ending December 2020. Its Facilisgroup business has continued to perform well during the pandemic, while its Brand Addition business has continued to improve since flagging weakness in September.

Many of the largest detractors during November were simply the strongest performers of recent months giving back some of their gains as investors sold winners to buy into the value rally. This impacted our holdings in YouGov and Games Workshop. Importantly, underlying trading in both businesses remains strong and we do not see any fundamental change to the investment case for either simply because of the announcement of successful COVID-19 vaccines. Both companies remain very attractive and we are excited by the opportunities that we see ahead for these businesses, and we have used share price volatility to add to our holdings.

The ongoing COVID-19 pandemic along with the US Presidential Election and Brexit trade negotiations have been key sources of volatility in recent months, and resolution on these three issues has, and will remain key for equity markets to return to some level of rational behaviour. At the time of writing, a number of countries have begun to administer the vaccine to the most vulnerable individuals, and therefore, despite further mandated restrictions, stock markets are now focused on how quickly the world can return to something approximating normality. Whilst the news of workable vaccines is clearly positive for markets and global economies, we remain mindful that any programme of mass vaccination will take many months to implement, and therefore we may see further volatility from third/fourth waves of the virus and lockdowns.

Politics never leaves us, and whilst the US election result has provided the hope of a more balanced global political environment, attention is now shifting to Brexit. From our perspective any form of clarity is positive for UK equities over the medium to long-term. Given how under-owned the UK market is and the discount it trades at compared with other global markets, we see any conclusion as having the potential to drive flows into UK equities regardless of whether we have a negotiated deal or we leave without one. The negotiations have in one form or another been going on for years, giving companies ample time to prepare their businesses for a no deal Brexit. We therefore see the risk of unexpected business disruption as relatively muted at an individual company level. Whilst there will undoubtedly be some sectors that are more exposed than others, we remain firmly of the belief that strong companies will prevail, regardless of the result of the negotiations. We continue to believe that smaller companies in particular will be able to react and adapt fastest to whatever form Brexit takes.

The Company’s investment strategy is focussed on quality growth investments in smaller companies, a style that has demonstrably worked for the long-term, and historically periods of heightened volatility, such as this, have proven to be excellent investment opportunities.

1Source: BlackRock as at 30 November 2020

23 December 2020

ENDS 

Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
3rd Oct 202312:26 pmPRNNet Asset Value(s)
3rd Oct 20237:00 amPRNTotal Voting Rights
2nd Oct 20236:13 pmPRNTransaction in Own Shares
2nd Oct 202311:14 amPRNNet Asset Value(s)
2nd Oct 20237:00 amPRNTotal Voting Rights
29th Sep 20237:02 pmPRNTransaction in Own Shares
29th Sep 20234:19 pmPRNPortfolio Update
29th Sep 202311:56 amPRNNet Asset Value(s)
29th Sep 20237:00 amPRNTotal Voting Rights
28th Sep 20236:22 pmPRNTransaction in Own Shares
28th Sep 202311:22 amPRNNet Asset Value(s)
28th Sep 20237:00 amPRNTotal Voting Rights
27th Sep 20236:13 pmPRNTransaction in Own Shares
27th Sep 202311:31 amPRNNet Asset Value(s)
26th Sep 20236:57 pmPRNTransaction in Own Shares
26th Sep 202311:15 amPRNNet Asset Value(s)
26th Sep 20237:00 amPRNTotal Voting Rights
25th Sep 202312:15 pmPRNNet Asset Value(s)
22nd Sep 20236:55 pmPRNHolding(s) in Company
22nd Sep 20236:54 pmPRNTransaction in Own Shares
22nd Sep 202311:59 amPRNNet Asset Value(s)
21st Sep 202311:25 amPRNNet Asset Value(s)
21st Sep 202310:38 amPRNHolding(s) in Company
21st Sep 20237:00 amPRNTotal Voting Rights
20th Sep 202311:33 amPRNNet Asset Value(s)
20th Sep 20237:00 amPRNTotal Voting Rights
19th Sep 20235:43 pmPRNTransaction in Own Shares
19th Sep 202311:35 amPRNNet Asset Value(s)
18th Sep 20235:51 pmPRNTransaction in Own Shares
18th Sep 20231:34 pmPRNMandatory Closed Period Compliance with MAR
18th Sep 202311:31 amPRNNet Asset Value(s)
15th Sep 202311:25 amPRNNet Asset Value(s)
15th Sep 20237:00 amPRNTotal Voting Rights
14th Sep 202311:22 amPRNNet Asset Value(s)
13th Sep 20235:52 pmPRNTransaction in Own Shares
13th Sep 202311:19 amPRNNet Asset Value(s)
12th Sep 202311:12 amPRNNet Asset Value(s)
12th Sep 20237:00 amPRNTotal Voting Rights
11th Sep 202312:22 pmPRNNet Asset Value(s)
11th Sep 20237:00 amPRNTotal Voting Rights
8th Sep 20236:19 pmPRNTransaction in Own Shares
8th Sep 202312:18 pmPRNNet Asset Value(s)
8th Sep 20237:00 amPRNTotal Voting Rights
7th Sep 20235:51 pmPRNTransaction in Own Shares
7th Sep 202311:27 amPRNNet Asset Value(s)
6th Sep 20236:10 pmPRNTransaction in Own Shares
6th Sep 202312:03 pmPRNNet Asset Value(s)
5th Sep 202312:10 pmPRNNet Asset Value(s)
4th Sep 202311:39 amPRNNet Asset Value(s)
1st Sep 202311:35 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.